Discover 482 paid clinical trials in Providence, Rhode Island. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 482
Active & Responsive
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
for
Atopic Dermatitis
Location: Johnston RI, New York NY, Philadelphia PA,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT05995964
Phase2, Recruiting
Active & Responsive
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
for
Diabetic Peripheral Neuropathic Pain
Location: East Greenwich RI, Boston MA, Waterbury CT,
Sponsor: Vertex Pharmaceuticals Incorporated
Sex: All
Age: 18 - 70+
Code: NCT07231419
Phase3, Recruiting
Active & Responsive
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
for
Diabetic Peripheral Neuropathic Pain
Location: East Greenwich RI, Boston MA, Waltham MA, New York NY,
Sponsor: Vertex Pharmaceuticals Incorporated
Sex: All
Age: 18 - 70+
Code: NCT06628908
Phase3, Recruiting
Active & Responsive
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
for
Obesity, Overweight
Location: East Greenwich RI, Waterbury CT, Binghamton NY,
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT07684235
Phase3, Recruiting
Active & Responsive
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
A Study of HS235 for Treatment of Pulmonary Arterial Hypertension (PAH) in Adults
for
Pulmonary Arterial Hypertension
Location: Providence RI, Tampa FL
Sponsor: 35Pharma Inc
Sex: All
Age: 18+
Code: NCT07143448
Phase1, Phase2, Recruiting
Recovery Through Inhibitory Learning, Self-Efficacy Building, Problem Solving, and Community Building
for
Alcohol Use Disorder (AUD), PTSD
Location: Providence RI
Sponsor: University of Rhode Island
Sex: All
Age: 18+
Code: NCT07217795
Recruiting
L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML
for
Acute Myeloid Leukaemia (AML)
Location: Providence RI, Morristown NJ, Philadelphia PA,